We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Chris Wack Incannex Healthcare Ltd. shares were up 10% to $8.35 after the company said it has completed a highly constructive pre-investigational new drug application meeting with the Food and...
By Chris Wack Incannex Healthcare Ltd. said it has completed a highly constructive pre-Investigational New Drug application meeting with the U.S. Food and Drug Administration to discuss the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | -0.519 | -91.0526315789 | 0.57 | 0.755 | 0.044 | 4137154 | 0.27575163 | DE |
260 | -0.015 | -22.7272727273 | 0.066 | 0.755 | 0.029 | 3556036 | 0.23689321 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions